| Application no. and date | 14761702.1 (espacenet) (Federated) (European Patent Register), 20140826 | | Patent/reg. no. and date | DK/EP 3038654, 20191030 | | Publication date | 20160706 | | Priority no. and date | WO PCT/US2013/056680, 20130826, US 201461972933 P, 20140331 | | EP pub. no. and date |
EP 3038654 20160706 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/159809 | | Inventor | SHI, Victor Chengwei, c/o Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
LEFKOWITZ, Martin, c/o Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US,
RIZKALA, Adel Remond, c/o Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/194 (2006.01) , A61K 31/197 (2006.01) , A61K 31/216 (2006.01) , A61K 31/221 (2006.01) , A61K 31/225 (2006.01) , A61K 31/401 (2006.01) , A61K 31/41 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 9/10 (2006.01) , A61P 9/12 (2006.01) | | Title | Ny anvendelse | | Int. application no. | IB2014064074 | | Int. publication no. | WO2015028941 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
